Back to Kestra Advisory Services, LLC Kestra Advisory Services, LLC

CORTCORT

Showing 9 of 13 quarters

Position history for Kestra Advisory Services, LLCKestra Advisory Services, LLC's holdings in Corcept Therapeutics Incorporated

Yes. Kestra Advisory Services holds 8,170 shares of CORT (Corcept Therapeutics), worth $941,429, as of its Q3 2026 13F filing. It reduced the position by 2,744 shares (-25.1%) from Q2 2026. Kestra Advisory Services has held CORT since Q2 2026, across 2 quarterly 13F filings.

Current Value

$941,429

Current Shares

8,170

Total Value Change

+$548,697

Total Shares Change

-316

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
8,170
-25.1%
$941,4290.0%$115.23
0
2026-Q2
New
10,914
—
$948,9720.0%$86.95
35
2026-Q1
Exited
0
-100.0%
$00.0%$40.31
0
2025-Q4
Decreased
5,194
-24.1%
$180,7510.0%$34.80
0
2025-Q3
Decreased
6,847
-4.8%
$569,0540.0%$83.11
0
2025-Q2
Increased
7,193
+4.1%
$527,9660.0%$73.40
25
2025-Q1
Decreased
6,907
-27.5%
$788,9180.0%$114.22
0
2024-Q4
Increased
9,525
+12.2%
$479,9650.0%$50.39
27
2024-Q3
Decreased
8,486
-65.1%
$392,7320.0%$46.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used